Industry

Biotechnology ETFs

Funds with at least half of their holdings in the Biotechnology industry. Pick one to see news about the companies inside it.

BBHVanEck Biotech
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
15.2% of BBHMore BBH news →
BBPVirtus LifeSci Biotech Products
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
4.0% of BBPMore BBP news →
CANCTema Oncology
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
11.7% of CANCMore CANC news →
FBTFirst Trust NYSE Arca Biotechnology Index Fund
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
3.9% of FBTMore FBT news →
GNOMGlobal X Genomics & Biotechnology
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
6.7% of GNOMMore GNOM news →
HELXFranklin Genomic Advancements
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
4.6% of HELXMore HELX news →
IBBiShares Biotechnology
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.8% of IBBMore IBB news →
IBBQInvesco Nasdaq Biotechnology
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.1% of IBBQMore IBBQ news →
IBRNiShares Neuroscience and Healthcare
Seeking Alpha · 28 Oct 2026, 20:02 UTC
Biogen anticipates $250M of run rate synergies by end of 2027 as it raises 2026 non-GAAP EPS to $12.20-$13 (NASDAQ:BIIB) | Seeking Alpha
4.2% of IBRNMore IBRN news →
IDNAiShares Genomics Immunology and Healthcare
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
13.1% of IDNAMore IDNA news →
MULTFranklin Multisector Income
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
4.6% of MULTMore MULT news →
PBEInvesco Biotechnology & Genome
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
5.4% of PBEMore PBE news →
PTHInvesco Dorsey Wright Healthcare Momentum
Market Screener · 28 Oct 2026, 12:21 UTC
United Therapeutics Corporation Receives FDA Clearance To Proceed With Clinical Trial For Treprostinil-Iloprost SMI In Pulmonary Arterial Hypertension
3.4% of PTHMore PTH news →
QOWZInvesco Nasdaq Free Cash Flow Achievers
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.1% of QOWZMore QOWZ news →
WDNAWisdomTree BioRevolution Fund
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.0% of WDNAMore WDNA news →
XBIState Street(R) SPDR(R) S&P(R) Biotech
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
2.1% of XBIMore XBI news →
XDNAKelly CRISPR & Gene Editing Technology
24/7 Wall St. · 28 Oct 2026, 22:00 UTC
Thermo Fisher Scientific Reaches $704 and a New 52-Week High
9.9% of XDNAMore XDNA news →

European (UCITS) Biotechnology funds

We show news for a similar US-listed fund.

NBTKInvesco Nasdaq Biotech UCITS ETFNews via IBBQ